Vertex Pharmaceuticals, Inc. (VRTX)

439.24 -2.12 (-0.48%) USD  |  NASDAQ  |  Jan 20, 11:43
More

Vertex Pharmaceuticals Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Pfizer Inc. Upgrade
Amgen, Inc. Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade